Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 207,525 |
|
|||||
| News | - | ||||||
| Day High | 200.68 | Low High |
|||||
| Day Low | 190.73 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc | MDGL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -11.64 | -5.69% | 193.01 | 11:15:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 200.68 | 190.73 | 200.68 | 204.65 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,024 | 207,525 | $ 194.22 | $ 40,305,036 | - | 119.7604 - 322.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:16:06 | 1 | $ 193.2699 | USD |
Madrigal Pharmaceuticals (MDGL) Options Flow Summary
Madrigal Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.84B | 19.90M | - | 0 | -373.63M | -18.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Madrigal Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MDGL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 227.78 | 227.90 | 190.73 | 212.86 | 521,161 | -34.77 | -15.26% |
| 1 Month | 258.54 | 268.22 | 190.73 | 233.79 | 391,865 | -65.53 | -25.35% |
| 3 Months | 218.87 | 298.00 | 168.2462 | 235.13 | 604,963 | -25.86 | -11.82% |
| 6 Months | 124.15 | 298.00 | 119.7604 | 219.41 | 479,210 | 68.86 | 55.47% |
| 1 Year | 305.83 | 322.67 | 119.7604 | 213.30 | 428,244 | -112.82 | -36.89% |
| 3 Years | 130.28 | 322.67 | 52.33 | 178.33 | 316,158 | 62.73 | 48.15% |
| 5 Years | 106.12 | 322.67 | 52.33 | 158.00 | 256,111 | 86.89 | 81.88% |
Madrigal Pharmaceuticals Description
| Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. |
